Prevention of Cardiovascular Risk in Patients with Systemic Sclerodermia

Abstract

Cardiovascular risk is a major concern in modern medicine in patients with systemic scleroderma (SSD). In these patients, the prevention of cardiovascular diseases, the identification of risk factors and the prediction of cardiovascular risk are of scientific and practical importance, thereby reducing morbidity, disability and mortality, as well as improving the quality and prognosis of patients. When determining the frequency of cardiovascular risk factors in patients with systemic scleroderma, it is important to identify such indicators as heredity, smoking, rheumatoid factor, hypercholesterolemia, abdominal obesity and C-reactive protein.